EBOOK-CELL THERAPY
Autor: GUTIERREZ
________________________________________

Precio: 93.5€
Fecha Publicación: 01-JAN-10,
Edición: 01
ISBN: 8448173171
EAN: 9788448173173
Idioma: ESP

Estado: Stock disponible


  


Descripción | Tabla de Contenidos | Biografía autor/es |

Descripción

  • This work is of maximum quality which includes high-level collaborations.
  • It covers everything from general aspects of cell therapy, all the way up to its application in each clinical case.
  • Approved by Dr. Edward Donnall Thomas, Nobel Prize for Medicine in 1990 for this studies and discoverries in cell transplants for the treatment of diseases.
  • This work has been divided into three sections:
I.-General aspects of somatic cell therapy, with various chapters which cover its:origin, evolution, biology, biomaterials, and ethics, among others areas.
II.-Cell sources for somatic cell therapy. Some of the chapters includes subject areas coming from cells of the umbilical cord blood transplantation, hepatic stem cells, amniotic fluid derived pluripotent stem cells.
III.-Therapeutic targets for somatic cell therapy. The subject areas here are about therapeutic applications, such as cell regeneration in Parkinson¿s disease, bone regeneration, etc¿
  • This is a totally updated book ( and with the exception of some articles) no other publication treats this subject matter this way or in such depth.

Target :Internal Phycisians ; Clinical Phycisians ; Specialist in transplants; Cardiologist, Oncologist, Endocrinologist, Inmunologist; Hematologist; Specialist in Genetics, Surgeons, Neurosurgeons; Researchers.
Target 2º: Medical students of the last years, Residents.

Tabla de Contenidos

    Preface. Editor¿s preliminary considerations
    Part I:General aspects of somatic cell therapy
  1. ORIGIN, EVOLUTION, AND DIRECTIONS OF HUMAN SOMATIC CELL THERAPY.
  2. THE BIOLOGY OF TISSUE AND ORGAN REGENERATION.
  3. PRODUCTION OF CELL-BASED MEDICINES FOR SOMATIC CELL THERAPY.
  4. BIOMATERIALS FOR SOMATIC CELL THERAPY
  5. BIOSAFETY ISSUES IN HUMAN CELL THERAPY
  6. REGULATORY ASPECTS OF HUMAN SOMATIC CELL THERAPY
  7. ETHICAL ASPECTS OF HUMAN SOMATIC CELL THERAPY.
    Part II Cell sources for somatic cell therapy
  8. MULTIPOTENT PROGENITOR CELL POPULATIONS OBTAINED FROM BONE MARROW.
  9. THERAPEUTIC POTENTIAL OF CELLS FROM NON-MARROW POSTNATAL TISSUES.
  10. LIVER RECONSTITUTION BY HEPATIC STEM AND PROGENITOR CELLS.
  11. ALLOGENIC CELL THERAPY TO TREAT SKIN LOSS.
  12. UMBILICAL CORD BLOOD TRANSPLANT.
  13. AMNIOTIC FLUID DERIVED PLURIPOTENT STEM CELLS.
  14. THERAPEUTIC APPLICATIONS OF HUMAN EMBRYONIC STEM CELLS.
    Part III Therapeutic targets for somatic cell therapy.
  15. CLINICAL TRIALS IN SOMATIC CELL THERAPY.
  16. BONE MARROW TRANSPLANTATION FOR THE REGENERATION OF THE HEMATOPOIETIC SYSTEM.
  17. SKIN REGENERATION.
  18. AUTOLOGOUS CHONDROCYTE IMPLANTATION FOR CARTILAGE REGENERATION
  19. BONE REGENERATION USING BONE MARROW STEM CELLS.
  20. HEART SOMATIC CELL THERAPY.
  21. USE OF ENDOTHELIAL PROGENITORS TO TREAT ISQUEMIA.
  22. TREATMENT OF DIGESTIVE FISTULA USING ADIPOSE-DERIVED STEM CELLS.
  23. ADULT NEURAL STEM CELLS; PROSPECTS FOR BRAIN REPAIR.
  24. CELL THERAPY FOR PARKINSON¿S DISEASE AND OTHER CNS DISORDERS.
  25. CORNEAL REGENERATION BY MEANS OF SOMATIC CELL THERAPY.
  26. LUNG REGENERATION BY STEM CELLS.
  27. CELL THERAPY OF RENAL FAILURE.
  28. SOMATIC CELL THERAPY FOR URINARY INCONTINENCE.
  29. CELL REPLACEMENT THERAPY FOR DIABETES.
  30. THERAPEUTIC STRATEGIES USING GENETICALLY MODIFIED CELLS.
  31. ADAPTIVE CELLULAR IMMUNOTHERAPY WITH REGULATORY T CELLS

Biografía autor/es

  • EDITORS
    Damián García Olmo.Surgery Department and Cell Therapy Unit. La Paz University Hospital. Madrid, Spain.
    Jose Manuel García-Verdugo. Laboratorio de Morfología Celular. Unidad Mixta CIPF-UVEG. Valencia, Spain.
    Jorge Alemany. Cellerix, S.L. Madrid, Spain.
    José A. Gutiérrez-Fuentes.Lilly Foundation. Madrid, Spain.
    AUTHORS
    Arturo Álvarez-Buylla. Department of Neurological Surgery and Institute for Regenerative Medicine. University of California at San Francisco. San Francisco, CA, USA.
    Takayuki Ashara.Department of Regenerative Medicine Science. Tokai University School of Medicine, Kanagawa. Stem Cell Translational Research. RIKEN Center for Developmental Biology Institute of Biomedical Research and Innovation. Kobe, Japan
    Anthony Atala. Wake Forest Institute for Regenerative Medicine. Wake Forest University Health Sciences. Winston-Salem, North Carolina, USA.
    Rosa Bacchetta. San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET). Milan, Italy.
    Pedro Baptista. Wake Forest Institute for Regenerative Medicine. Wake Forest University Health Sciences. Winston-Salem, North Carolina, USA.
    Antonio Bernad.Head of Department. Regenerative Cardiology. Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III. Madrid, Spain.
    Robert C. Bielby. Stem Cells and Regenerative Medicine. Section on Experimental Medicine & Toxicology. Imperial College Faculty of Medicine Hammersmith Hospital London, UK.
    Anne Bishop. Stem Cells and Regenerative Medicine. Section on Experimental Medicine & Toxicology. Imperial College Faculty of Medicine Hammersmith Hospital London, UK.
    Thierry Bovy. Cell Therapy. Lonza Verviers SPRL. Verviers, Belgium.
    Natividad Calvente. Spanish Drug Regulatory Agency. Ministerio de Sanidad y Consumo. Madrid, Spain.
    Sara Campiña.LOGICELL TECH, S.L. Madrid, Spain II.
    Rita Pilar Cervera. Gene Expresión Laboratory. Salk Institute for Biological Studies. La Jolla, CA, USA.
    Michael B. Chancellor. McGowan Institute for Regenerative Medicine and Department of Urology. University of Pittsburgh. Pittsburgh, Pennsylvania, USA.
    Mariana D. Dabeva. Department of Medicine. Marion Bessin Liver Research Center. Albert Einstein College of Medicine. New York, USA.
    Dawn M. Delo. Wake Forest Institute for Regenerative Medicine. Wake Forest University Health Sciences. Winston-Salem, North Carolina, USA.
    Fernando de Miguel. Laboratorio de Terapia Celular. Fundación Investigación Biomédica. Hospital La Paz. Madrid, Spain.
    Marcela del Río. Regenerative medicine Unit, Epithelial Biomedicine Division . CIEMAT, CIBER-ER, ISCIII. Madrid, Spain.
    Alla Dolnikov. Sydney Cord and Marrow Research Facility. Sydney Children¿s Hospital. Sydney, Australia.
    Francisco Fernández-Avilés. Professor of Cardiovascular Medicine. Chairman of the Department of Cardiology. Hospital General Universitario Gregorio Marañón. Madrid, Spain.
    Gemma Fernández-Miguel Cellerix, S.L. Madrid, Spain.
    William H. Fissell. Associate Staff| Nephrology and Hypertension. Departments of Nephrology and Hypertension and Biomedical Engineering. Cleveland Clinic. Cleveland, Ohio, USA.
    Aaron J. Fleischman. Department of Biomedical. Engineering Cleveland Clinic. Cleveland, Ohio, USA.
    Rui P. Galvao. Department of Neurological Surgery and Institute for Regenerative Medicine. University of California at San Francisco. San Francisco, CA, USA. Instituto Gulbenkian de Ciencia. Oeiras, Portugal.
    Mariano García-Arranz. Surgery Department and Cell Therapy Unit. La Paz University Hospital. Madrid, Spain.
    Javier García-Castro.Oncology Department. Hospital Universitario del Niño Jesús. Madrid, Spain.
    Adolfo García-Ocaña. Division of Endocrinology. University of Pittsburgh. School of Medicine. Pittsburgh, Pennsylvania, USA.
    Damián García-Olmo. Surgery Department and Cell Therapy Unit. La Paz University Hospital. Madrid, Spain.
    José Manuel García-Verdugo. Laboratorio de Morfología Celular. Unidad Mixta CIPF-UVEG. Valencia, Spain.
    Manuel A. González. Cellerix, S.L. Madrid, Spain.
    Adam Goulburn. Monash Immunology and Stem Cell Laboratories (MISCL). Monash University . Melbourne, Victoria, Australia.
    Maria-Grazia Roncarolo San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Università Vita-Salute San Raffaele. Milan, Italy.
    Silvia Gregori.San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET). Milan, Italy.
    Pedro L. Herrera. Department of Genetic Medicine and Development. University of Geneva Medical School. Geneva, Switzerland.
    Dolores Herreros. Surgery Department and Cell Therapy Unit. La Paz University Hospital. Madrid, Spain.
    Edwin M. Horwitz. Division of Oncology/Blood and Marrow Transplantation. The Children¿s Hospital of Philadelphia. The University of Pennsylvania School of Medicine. Philadelphia, USA.
    H. David Humes.Department of Internal Medicine. University of Michigan. School of Medicine, Ann Arbor. Michigan, USA.
    Juan Carlos Izpisúa Belmonte. Gene Expresión Laboratory. Salk Institute for Biological Studies. La Jolla, CA, USA. Center for Regenerative Medicine. arcelona, Spain.
    José L Jorcano. Biomedicine Division. CIEMAT and Genoma Spain Foundation. Madrid, Spain.
    Sile Lane. Stem Cells and Regenerative Medicine. Section on Experimental Medicine & Toxicology. Imperial College Faculty of Medicine Hammersmith Hospital London, UK.
    Fernando Larcher. Cutaneous Disease Modeling Unit. Epithelial Biomedicine Division. CIEMAT, CIBER-ER, ISCIII. Madrid, Spain.
    Sang Jin Lee. Wake Forest Institute for Regenerative Medicine. Wake Forest University Health Sciences. Medical Center Boulevard. Winston-Salem, NC, USA.
    Masaaki Li. Stem Cell Translational Research. RIKEN Center for Developmental Biology. Institute of Biomedical Research and Innovation.Kobe, Japan.
    José López-Barneo. Professor of Physiology. Instituto de Biomedicina de Sevilla (IBiS). Hospital Universitario Virgen del Rocio / CSIC. Universidad de Sevilla. Sevilla, Spain.
    Álvaro Meana. Centro de Transfusiones del Principado de Asturias. Oviedo, Spain.
    Adolfo Mínguez-Castellanos. Servicio de Neurología. Hospital Universitario Virgen de las Nieves. Granada, Spain.
    Tracy A. O¿Brien. Paediatric and Adolescent Haematologist/Oncologist Head, Cord and Marrow Transplant Program Centre for Children¿s Cancer & Blood Disorders Sydney Children¿s Hospital Sydney, Australia.
    María Pascual. Regulatory Affairs Director. Cellerix, S.L. Madrid, Spain.
    Isabel Pascual. Surgery Department and Cell Therapy Unit. La Paz University Hospital. Madrid, Spain.
    Graziella Pellegrini. Department of Biochemistry, University of Modena e Reggio Emilia, Modena. Regional Research Center on Epithelial Stem Cells. Eye Bank Foundation of Veneto. SS. Giovanni e Paolo Hospital. Venice, Italy.
    Bryon E. Petersen. Department of Pathology. University of Florida. Gainesville, FL, USA.
    Lars Peterson. Gothenburg Medical Center. Västra Frölunda, Sweden.
    Felipe Prosper. Hematology and Cell Therapy Area. Clínica Universitaria de Navarra. Universidad de Navarra. Pamplona, Spain.
    Helen J. Rippon. Stem Cells and Regenerative Medicine. Section on Experimental Medicine & Toxicology. Imperial College Faculty of Medicine Hammersmith Hospital London, UK.
    Clara Isabel Rodríguez. Unidad de InvestigaciónHospital de CrucesBarakaldo, Bizkaia, Spain.
    José A. Rodríguez-Gómez. Laboratorio de Investigaciones Biomédicas y Dpto. de Fisiología. Hospital Universitario Virgen del Rocío. Universidad de Sevilla. Sevilla, Spain.
    Vicent Ronfard. Chief Scientific Officer. Organogenesis Inc. Canton, Massachusetts, USA.
    Ciril Rozman. Postgraduate School of Haematology ¿Farreras Valentí¿. Hospital Clínic of Barcelona. University of Barcelona. Barcelona, Spain.
    Shuvo Roy. Department of Biomedical Engineering. Cleveland Clinic. Cleveland, Ohio, USA.
    Daniel Rubio. Immunology and Oncology Department. National Centre of Biotechnology (CNB-CSIC). Madrid, Spain.
    Pedro L. Sánchez. Assistant Professor of Cardiovascular Medicine. Coordinator of the Cardiovascular Research Program. Department of Cardiology. Hospital General Universitario Gregorio Marañón. Madrid, Spain.
    Marta Serafíni. Centro Ricerca M. Tettamanti, Clinica Pediatrica. Università Milano-Bicocca, Ospedale San Gerardo. Monza, Italy.
    Daniel Serrão. Bioethics Institute of the Portuguese Catholic University. Porto, Portugal.
    David A. Shafritz. Department of Medicine and Cell Biology. Marion Bessin Liver Research Center. Albert Einstein College of Medicine. New York, USA.
    Shay Soker. Wake Forest Institute for Regenerative Medicine. Wake Forest University Health Sciences. Winston-Salem, North Carolina, USA.
    Carolina Soler-Botija. Gene Expresión Laboratory. Salk Institute for Biological Studies. La Jolla, CA, USA.
    Andrew F. Stewart. Division of Endocrinology. University of Pittsburgh. School of Medicine. Pittsburgh, Pennsylvania, USA.
    Colin L. Stewart. Mammalian Developmental Biology Section. Cancer and Developmental Biology Laboratory. National Cancer Institute. Frederick, Maryland, USA.
    Juan J. Toledo-Aral. Laboratorio de Investigaciones Biomédicas y Dpto. de Fisiología. Hospital Universitario Virgen del Rocío. Universidad de Sevilla. Sevilla, Spain.
    Edward Donnall Thomas. Nobel Prize Laureate in Physiology and Medicine. Clinical Division, Fred Hutchinson Cancer Research Center. Seattle, Washington, USA.
    Jacobo Trébol. Surgery Department and Cell Therapy Unit. La Paz University Hospital. Madrid, Spain.
    Alan Trounson. Monash Immunology and Stem Cell Laboratories (MISCL). Monash University. Melbourne, Victoria, Australia.
    Álvaro Urbano-Ispizua. Postgraduate School of Haematology ¿Farreras Valentí¿. Hospital Clínic of Barcelona. University of Barcelona. Barcelona, Spain.
    Catherine M. Verfaillie. Professor of Medicine. Director, Stamcelinstitut, K U Leuven. Leuven, Belgium.
    John E. Wagner. Director, Blood and Marrow Transplant Program. Department of Medicine and Pediatrics. University of Minnesota. Minneapolis, Minnesota, USA.
    Jennifer M. Williams. Department of Pathology. University of Florida. Gainesville, FL, USA.
    James J. Yoo. Wake Forest Institute for Regenerative Medicine. Wake Forest University Health Sciences. Medical Center Boulevard. Winston-Salem, NC, USA